Healthcare

This research service focuses on prescription drugs for the treatment of obesity. A global product and pipeline assessment is provided for marketed and investigational products. Segmentation by drug class is provided, along with additional supporting information, such as clinical trial timelines and results, historical and projected launch timeline...

This research service studies the Indian Diabetes market. It provides the number of Type 1 and Type 2 diabetic patients in India across different age groups and forecasts these numbers up to 2030. It provides a detailed analysis of the two major segments of the market, the insulin market segment and the anti-diabetic medications segment, which incl...

This research service presents a study of the interventional radiology and cardiology equipment market in the Asia-Pacific region. It provides an in-depth analysis of the current trends, market size, revenue forecast, unit shipment forecast, technology trends, drivers and restraints, and penetration analysis of the interventional radiology and car...

This research service presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type, and region. It addresses the major issues and challenges, unmet needs, and emerging trends in the market. Detailed information has been provided on s...

This issue of Vital Signs discusses the change in 2015 Mammogram Guidelines, NeoGenomics' acquistion of Clarient from GE, and Tute Genomics' acquisition of Knome.

This research service presents an analysis of the digital and computed radiography market in Asia-Pacific. It provides an in-depth analysis of the current trends, market size, revenue forecast, unit shipment forecast, technology trends, drivers and restraints, market penetration, market attractiveness, and game changing strategies, both in the dig...

This issue of Vital Signs, released in August 2015, discusses The Real Fight Against Cancer: The Struggle to make Drugs Affordable, OPKO Health's acquisition of Bio-Reference Laboratories, Health Insurance Company Mergers  How will Consumers Fare?, and Illumina's acquisition of GenoLogics.

Where should one invest or sell in the aftermath of the financial crisis of 2008 and the on-going European debt crisis? While rich countries have shown very slow growth rates, emerging markets have shown much greater resilience. To increase profitability, you can either find new markets to increase sales, or seek opportunities to invest. Emerging ...